Clover Health Investments Corp
$ 2.04
0.49%
14 Apr - close price
- Market Cap 1,065,075,000 USD
- Current Price $ 2.04
- High / Low $ 2.12 / 2.02
- Stock P/E N/A
- Book Value 0.60
- EPS -0.17
- Next Earning Report 2026-05-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.10 %
- ROE -0.26 %
- 52 Week High 3.92
- 52 Week Low 1.58
About
Clover Health Investments, Corp. The company is headquartered in Franklin, Tennessee.
Analyst Target Price
$2.82
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-04 | 2025-11-04 | 2025-08-04 | 2025-05-05 | 2025-03-10 | 2024-11-06 | 2024-08-05 | 2024-05-07 | 2024-03-12 | 2023-11-06 | 2023-08-08 | 2023-05-09 |
| Reported EPS | -0.0459 | -0.05 | 0.0329 | 0.051 | -0.05 | -0.02 | 0.01 | -0.04 | -0.14 | -0.09 | -0.06 | -0.15 |
| Estimated EPS | -0.0545 | -0.01 | -0.0187 | -0.07 | -0.065 | -0.04 | -0.05 | -0.07 | -0.14 | -0.11 | -0.15 | -0.18 |
| Surprise | 0.0086 | -0.04 | 0.0516 | 0.121 | 0.015 | 0.02 | 0.06 | 0.03 | 0 | 0.02 | 0.09 | 0.03 |
| Surprise Percentage | 15.7798% | -400% | 275.9358% | 172.8571% | 23.0769% | 50% | 120% | 42.8571% | 0% | 18.1818% | 60% | 16.6667% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.03 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CLOV
2026-04-10 23:39:27
Joseph Frank Oldakowski, VP of Finance and Controller at Clover Health Investments, Corp. (CLOV), has filed an initial ownership report (Form 3) disclosing beneficial ownership of 311,169 shares of Class A common stock. These shares are part of unvested time-based restricted stock units granted on June 16, 2025, and December 19, 2025, and represent equity-based compensation rather than open-market transactions. The filing clarifies that this is an initial statement of ownership, not a buy or sell transaction.
2026-04-09 22:12:41
Clover Health Investments (CLOV) interim CFO Joseph Clay Thornton reported a beneficial ownership of 1,238,684 shares of Class A common stock in an amended Form 3. This total includes 912,860 shares from unvested time-based restricted stock unit awards. The filing clarifies his total equity exposure with the company, dating back to RSU grants in 2024 and 2025.
2026-04-09 22:10:41
Clover Health Investments' interim CFO, Joseph Clay, has filed a Form 3 disclosing his initial beneficial ownership in the company. The filing indicates that Clay holds 1,238,684 shares of Class A common stock, which includes 912,860 shares underlying unvested Restricted Stock Unit (RSU) awards granted on February 16, 2024, October 15, 2024, and December 19, 2025. This Form 3 establishes his baseline equity position as an officer of Clover Health.
2026-04-07 20:39:18
Clover Health Investments CEO of Medicare Advantage, Jamie L. Reynoso, had 6,197 shares of Class A Common Stock withheld on April 3, 2026, to cover tax obligations. This withholding was due to the vesting of 6.25% of restricted stock units granted on January 3, 2023. Following this transaction, Reynoso directly holds 2,869,922 shares of Class A Common Stock, with remaining RSUs vesting in quarterly installments until January 2027.
2026-04-03 21:10:03
Clover Health Investments' CEO of Clover Care Services, Brady Patrick Priest, was granted 191,261 shares of Class A Common Stock as time-based restricted stock units (RSUs). These RSUs, part of his equity compensation with no cash purchase price, will vest over time, with 25% vesting on April 1, 2027, and the remainder in quarterly installments through April 1, 2030, contingent on his continued employment. Following this award, Priest directly holds 2,189,845 shares of Class A Common Stock.
2026-04-03 20:20:34
Clover Health Investments (CLOV) has granted its Chief Legal Officer, Karen Soares, 382,522 Restricted Stock Units (RSUs) of Class A common stock. These RSUs were awarded at no cash cost, increasing her direct ownership to 1,582,583 shares. The vesting schedule dictates that 25% will vest on April 1, 2027, with the remainder vesting in quarterly installments until April 1, 2030, contingent on her continued employment.
